The landscape of managing diabetes is changing with the introduction of transdermal GLP-1 delivery . These convenient delivery systems offer a possibly more comfortable alternative to injections for individuals dealing with type 2 diabetes . These patches deliver a GLP-1 agonist directly through the dermis , bypassing the necessity for daily inject